SOFOVIR AND DACLAHEP TABLETS

Get a Price/Quote

SOFOVIR AND DACLAHEP TABLETS Specification

Salt Composition
Sofosbuvir 400mg + Daclatasvir 60mg

Origin of Medicine
India

Pacakaging (Quantity Per Box)
28 tablets

Dosage Form
Film-coated tablets

Indication
Treatment of genotype 1 to 6 chronic HCV infection

Drug Type
Allopathic

Ingredients
Sofosbuvir 400mg & Daclatasvir 60mg

Physical Form
Tablets

Function
Antiviral therapy for HCV

Recommended For
Chronic Hepatitis C Virus (HCV) Infection

Dosage
As directed by physician, typically one tablet daily

Dosage Guidelines
Oral administration, do not crush or chew, follow medical advice

Suitable For
Adults

Quantity
28 Tablets per box

Storage Instructions
Store below 30C, protected from moisture and light

SOFOVIR AND DACLAHEP TABLETS Trade Information

Packaging Details
PACK OF 28 TABLETS

Main Domestic Market
All India

About SOFOVIR AND DACLAHEP TABLETS

Sofovir And Daclahep

Specifications:-

Brand Name :Daclahep
Content :Daclatasvir
Strengths : 60 mg
Form : Tablets
Packing : Pack of 28Tablets
Uses : Treatingchronic hepatitis C virus (HCV) infection in certain patient
Manufactured by :Hetero

Note :- Sofovir And Daclahep Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug..............

How Does the Combination Work?

Sofovir and Daclahep tablets contain Sofosbuvir and Daclatasvir, which target different proteins essential for hepatitis C virus replication. This dual action increases treatment effectiveness, offering a high cure rate when used in combination therapy, as recommended by healthcare professionals.

Who Should Use These Tablets?

These antiviral tablets are suitable for adults diagnosed with chronic HCV infection (genotypes 1 to 6). Use of this medication in children is not advised unless a doctor specifically prescribes it. A prescription is required to obtain and use these tablets safely.

Administration and Dosage Guidelines

Take the tablets orally with waterdo not crush or chew them. The recommended dosage is typically one tablet daily, but always follow your physicians instructions for the best results. Store the tablets in original packaging, below 30C, protected from light and moisture.

FAQs of SOFOVIR AND DACLAHEP TABLETS:

Q: How should SOFOVIR and DACLAHEP Tablets be taken?

A: These tablets should be swallowed whole with water, following the prescribed dosage by your physician. Do not crush or chew the film-coated tablets, and always take them at the same time daily unless advised otherwise by your healthcare provider.

Q: What is the primary use of SOFOVIR and DACLAHEP Tablets?

A: SOFOVIR and DACLAHEP are used in combination therapy to treat chronic hepatitis C virus (HCV) infection (genotypes 1-6) in adults. They are prescribed under medical supervision to enhance the likelihood of achieving a sustained virologic response.

Q: When can results be expected from this antiviral therapy?

A: Treatment durations may vary, but noticeable improvement is usually observed within several weeks, with full course lengths often ranging from 12 to 24 weeks. Your physician will monitor your progress during therapy.

Q: Where should these tablets be stored?

A: Store the tablets in their original packaging, below 30C, away from direct sunlight, moisture, and heat. Ensure they are kept out of reach of children and not in areas with fluctuating temperatures.

Q: What side effects should be monitored during therapy?

A: Common side effects may include fatigue, headache, nausea, and difficulty sleeping. If you experience severe or unexpected symptoms, contact your healthcare provider promptly for guidance.

Q: Is a prescription required to purchase these tablets?

A: Yes, these are prescription medicines and must only be taken under the supervision of a qualified medical professional. Always obtain your medication from a reputable pharmacy or distributor.

Q: What are the advantages of using SOFOVIR and DACLAHEP together?

A: The combination therapy specifically targets the hepatitis C virus at multiple points in its replication process, resulting in higher cure rates, rapid viral suppression, and improved patient outcomes when taken as directed.

Tell us about your requirement